Anderson Hoagland & CO Gilead Sciences, Inc. Transaction History

Anderson Hoagland & CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 Apr 23, 2020	SELL	$62.63 - $80.22 $715,234 - $916,112	-11,420 Closed	0 $0
Q2 2019 Jul 03, 2019	SELL	$61.87 - $69.38 $997,344 - $1.12 Million	-16,120 Reduced 58.53%	11,420 $711,000
Q1 2018 Apr 24, 2018	SELL	$72.84 - $88.8 $296,823 - $361,860	-4,075 Reduced 12.89%	27,540 $2.08 Million
Q3 2017 Oct 17, 2017	BUY	$72.11 - $85.47 $2.28 Million - $2.7 Million	31,615	31,615 $2.56 Million

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Anderson Hoagland & CO, based on Form 13F filings with the SEC.

Stay updated on Anderson Hoagland & CO with notifications on news.